Medifast, Inc.
Consumer CyclicalNYSE:MED · New York Stock Exchange
-$0.03 today
Vol 0.10M · Avg 0.22M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$346.1M of revenue converted into -$20.0M of net income for the selected period. Gross margin is 69.9% and net margin is -6.8%, showing how much revenue survives after costs and taxes. EPS is $-1.83, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $385.8M -36.0% | $602.5M -43.8% | $1.1B -32.9% | $1.6B +4.8% | $1.5B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $110.6M -29.9% | $157.8M -46.7% | $296.2M -35.3% | $458.2M +15.0% | $398.5M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $275.2M -38.1% | $444.6M -42.7% | $775.9M -32.0% | $1.1B +1.1% | $1.1B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 71.3% -2.5pp | 73.8% +1.4pp | 72.4% +1.0pp | 71.3% -2.5pp | 73.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $289.4M -34.5% | $441.7M -32.0% | $649.4M -32.0% | $955.6M +4.9% | $911.4M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $289.4M -34.5% | $441.7M -32.0% | $649.4M -32.0% | $955.6M +4.9% | $911.4M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $10.5M -17.4% | $12.7M -3.1% | $13.1M +19.4% | $11.0M +61.2% | $6.8M | $374.2M | $1.2B | $631.8M |
| EBITDA | $4.9M -70.5% | $16.5M -88.4% | $141.9M -27.5% | $195.7M -12.2% | $222.9M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 1.3% -1.5pp | 2.7% -10.5pp | 13.2% +1.0pp | 12.2% -2.4pp | 14.6% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$14.2M -593.8% | $2.9M -97.7% | $126.4M -31.6% | $184.8M -14.5% | $216.2M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -3.7% -4.2pp | 0.5% -11.3pp | 11.8% +0.2pp | 11.6% -2.6pp | 14.2% | 16.6% | 24.1% | 22.0% |
| Interest Income | $5.5M +14.8% | $4.8M +92.9% | $2.5M | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $0 | $0 | $0 -100.0% | $701.0K | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $8.6M +843.2% | $909.0K -62.0% | $2.4M +420.6% | -$747.0K -567.0% | -$112.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$5.6M -248.9% | $3.8M -97.1% | $128.8M -30.0% | $184.1M -14.8% | $216.1M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -1.5% -2.1pp | 0.6% -11.4pp | 12.0% +0.5pp | 11.5% -2.6pp | 14.2% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $13.0M +668.5% | $1.7M -94.2% | $29.4M -27.4% | $40.5M -22.3% | $52.1M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$18.7M -993.0% | $2.1M -97.9% | $99.4M -30.8% | $143.6M -12.5% | $164.0M | $4.9B | $4.8B | $4.7B |
| Net Margin | -4.8% -5.2pp | 0.3% -8.9pp | 9.3% +0.3pp | 9.0% -1.8pp | 10.7% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$2 -994.7% | $0 -97.9% | $9 -29.0% | $13 -8.5% | $14 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$2 -994.7% | $0 -97.9% | $9 -28.5% | $13 -8.4% | $14 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $11.0M +0.5% | $10.9M +0.4% | $10.9M -2.8% | $11.2M -4.4% | $11.7M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $11.0M +0.2% | $11.0M +0.4% | $10.9M -3.1% | $11.3M -4.5% | $11.8M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Torrid Holdings Inc.
NYSE:CURV
$197.01M
1stdibs.Com, Inc.
NASDAQ:DIBS
$144.16M
China Automotive Systems, Inc.
NASDAQ:CAAS
$139.39M
Bassett Furniture Industries, Incorporated
NASDAQ:BSET
$136.02M
Clarus Corporation
NASDAQ:CLAR
$119.17M
Kewaunee Scientific Corporation
NASDAQ:KEQU
$105.28M
MasterBeef Group
NASDAQ:MB
$103.44M
a.k.a. Brands Holding Corp.
NYSE:AKA
$95.23M
Robo.ai Inc.
NASDAQ:AIIO
$53.81M
Faraday Future Intelligent Electric Inc.
FFAI
$27.51M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does MED generate?
Medifast, Inc. (MED) reported $385.79M of revenue in fiscal 2025.
Is MED profitable?
Medifast, Inc. (MED) reported -$18,672,000.00 of net income, with a net margin of -4.8%.
Explore More
Continue the stock analysis
Jump to another research area for this company.